Bone mineral density in pseudohypoparathyroidism type 1a.

Area of Science:

• Endocrinology
• Genetics
• Metabolic Bone Disease

Background:

• Pseudohypoparathyroidism type 1a (PHP1a) is characterized by parathyroid hormone (PTH) resistance.
• Tissue-specific imprinting of GNAS may limit PTH resistance to the renal cortex.
• Elevated PTH levels in PHP1a patients might paradoxically affect bone mineral density (BMD).

Purpose of the Study:

• To investigate bone mineral density (BMD) in children and adults with pseudohypoparathyroidism type 1a (PHP1a).
• To determine if secondary hyperparathyroidism impacts BMD in PHP1a patients.

Main Methods:

• Observational study at Johns Hopkins Medical Institutions.
• Included twenty-two children and adults diagnosed with PHP1a.
• Measured BMD Z-scores at lumbar spine, total hip, femoral neck, and total body using dual-energy x-ray absorptiometry.

Main Results:

• BMD Z-scores were not significantly reduced at any measured site.
• Total body and lumbar spine BMD Z-scores, corrected for height-for-age, were significantly greater than normal.
• Only 9% of subjects had BMD Z-scores below -2, and these had additional risk factors for low BMD.
• No correlation was found between PTH levels or BMI and BMD Z-scores.

Conclusions:

• Region-specific BMD is not reduced in PHP1a patients, even with secondary hyperparathyroidism.
• Total body BMD is significantly elevated in individuals with PHP1a.
• These findings challenge the assumption of low bone density in PHP1a due to PTH resistance.